Genetic Firewall for Live Medicines

French researchers develop a digital twin-based system to predict and prevent adverse reactions to live medicines.

A team of researchers at the French National Center for Scientific Research has developed a digital twin-based system to predict and prevent adverse reactions to live medicines.

The system uses a digital twin of the human body to simulate the behavior of live medicines and identify potential risks.

The researchers hope that this technology will revolutionize the development and use of live medicines, which are increasingly being used to treat a range of diseases.